Baxalta

All the email addresses for baxalta.com

{first}.{last}@baxalta.com
142 email addresses
http://smp.newshq.businesswire.com/pages/baxalta-and-award-winning-photographer-debut-unique-exhibition-showcasing-perspectives-those-i August 8, 2016
http://precisionbiosciences.com/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology June 6, 2016
http://smp.newshq.businesswire.com/pages/baxalta-receives-fda-approval-for-adynovate August 8, 2016
http://media.nektar.com/2015-12-07-baxalta-presents-additional-data-on-newly-approved-adynovate-and-plans-for-new-indications-during-57th-american-society-of-hematology-ash-annual-meeting January 1, 2016
http://media.nektar.com/2015-12-21-baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age January 1, 2016
http://smp.businesswire.com/pages/baxalta-receives-fda-approval-for-adynovate March 3, 2016
http://smp.businesswire.com/pages/baxalta-and-award-winning-photographer-debut-unique-exhibition-showcasing-perspectives-those-i September 9, 2016
http://qlifepro.com/press/20160404-19-26512/il-baxalta-incorporated-2 May 5, 2017
http://qlifepro.com/press/20160525-09-27177/il-baxalta-incorporated-3 May 5, 2017
http://qlifepro.com/press/20151116-20-25409/il-baxalta-incorporated July 7, 2017
http://itespresso.fr/press-release/baxalta-reoit-un-avis-positif-du-chmp-pour-lutilisation-doncaspar-pgaspargase-dans-lunion-europenne-comme-composant-dune-polythrapie-pour-traiter-la-leuceacu May 5, 2017
http://stockguru.com/2016/01/11/coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoint-in-phase-3-rheumatoid-arthritis-clinical-study-rapsody February 2, 2016
http://biotech-365.com/baxalta-to-initiate-a-first-in-human-clinical-trial-of-bax-826-an-investigational-extended-half-life-fviii-treatment-targeting-weekly-dosing-for-hemophilia-a May 5, 2016
http://prnewswire.com/news-releases/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age-300195716.html May 5, 2017
http://prnewswire.com/news-releases/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis-300199090.html July 7, 2017
http://rxtimes.com/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule August 8, 2016
http://media.nektar.com/2016-04-04-baxalta-expands-global-reach-of-adynovate-for-hemophilia-a-patients-with-approval-in-japan May 5, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx February 2, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-pricing-of-secondary-offering-of-common-stock/default.aspx March 3, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock/default.aspx July 7, 2017
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology/default.aspx July 7, 2017
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock-owned-by-baxter-international/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-declares-quarterly-dividend/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology/default.aspx March 3, 2016
http://pharmafocusasia.com/pressreleases/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule January 1, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-to-highlight-hemophilia-research-and-portfolio-innovation-at-eahad-annual-congress/default.aspx February 2, 2016
http://fiercebiotech.com/biotech/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for October 10, 2016
http://benzinga.com/pressreleases/15/11/n5979605/baxalta-to-advance-care-for-hemophilia-a-patients-with-fda-approval-of- May 5, 2017
http://ewhv.com/news/detail/baxalta-and-symphogen-establish-strategic-collaboratiion-to-accelerate-inno June 6, 2016
http://prnewswire.co.uk/news-releases/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-564834701.html November 11, 2016
http://prnewswire.com/news-releases/shire-to-combine-with-baxalta-creating-the-global-leader-in-rare-diseases-564834551.html July 7, 2017
http://qlifepro.com/press/20160525-09-27177/il-baxalta-incorporated-3 May 5, 2017
http://qlifepro.com/press/20151116-20-25409/il-baxalta-incorporated July 7, 2017
http://catalystportal.co.uk/news/latest_news/shireto_combine_with_baxalta_creating_the_global_leader_in_rare_dise1 July 7, 2016
http://sbcopeninnovation.co.uk/news/latest_news/shireto_combine_with_baxalta_creating_the_global_leader_in_rare_dise1 February 2, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx February 2, 2016
http://presseportal.ch/de/pm/100059179/100782550 September 9, 2017
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-pricing-of-secondary-offering-of-common-stock/default.aspx March 3, 2016
http://newsroom.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock/default.aspx July 7, 2017
http://newsroom.baxalta.com/press-releases/press-release-details/2015/baxalta-confirms-receipt-of-highly-conditional-unsolicited-proposal-from-shire/default.aspx July 7, 2017
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-cancels-presentation-at-34th-annual-jp-morgan-healthcare-conference/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-announces-secondary-offering-of-common-stock-owned-by-baxter-international/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-to-report-fourth-quarter-and-full-year-2015-results-on-february-16-2016/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-declares-quarterly-dividend/default.aspx March 3, 2016
http://smp.newshq.businesswire.com/pages/baxalta-and-award-winning-photographer-debut-unique-exhibition-showcasing-perspectives-those-i August 8, 2016
http://precisionbiosciences.com/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology June 6, 2016
http://smp.newshq.businesswire.com/pages/baxalta-receives-fda-approval-for-adynovate August 8, 2016
http://media.nektar.com/2015-12-07-baxalta-presents-additional-data-on-newly-approved-adynovate-and-plans-for-new-indications-during-57th-american-society-of-hematology-ash-annual-meeting January 1, 2016
http://media.nektar.com/2015-12-21-baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age January 1, 2016
http://smp.businesswire.com/pages/baxalta-receives-fda-approval-for-adynovate March 3, 2016
http://smp.businesswire.com/pages/baxalta-and-award-winning-photographer-debut-unique-exhibition-showcasing-perspectives-those-i September 9, 2016
http://pharmafocusasia.com/pressreleases/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule January 1, 2016
http://qlifepro.com/press/20160404-19-26512/il-baxalta-incorporated-2 May 5, 2017
http://itespresso.fr/press-release/baxalta-reoit-un-avis-positif-du-chmp-pour-lutilisation-doncaspar-pgaspargase-dans-lunion-europenne-comme-composant-dune-polythrapie-pour-traiter-la-leuceacu May 5, 2017
http://stockguru.com/2016/01/11/coherus-and-baxalta-announce-chs-0214-investigational-etanercept-biosimilar-met-primary-efficacy-endpoint-in-phase-3-rheumatoid-arthritis-clinical-study-rapsody February 2, 2016
http://vitessebiologics.com/contact-us May 5, 2016
http://biotech-365.com/baxalta-to-initiate-a-first-in-human-clinical-trial-of-bax-826-an-investigational-extended-half-life-fviii-treatment-targeting-weekly-dosing-for-hemophilia-a May 5, 2016
http://prnewswire.com/news-releases/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age-300195716.html May 5, 2017
http://prnewswire.com/news-releases/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for-unmet-medical-need-in-myelofibrosis-300199090.html July 7, 2017
http://rxtimes.com/baxalta-announces-u-s-availability-of-adynovate-a-new-treatment-for-adult-patients-with-hemophilia-a-with-a-simple-twice-weekly-dosing-schedule August 8, 2016
http://media.nektar.com/2016-04-04-baxalta-expands-global-reach-of-adynovate-for-hemophilia-a-patients-with-approval-in-japan May 5, 2016
http://newsroom.baxalta.com/overview/default.aspx February 2, 2016
http://newsroom.baxalta.com/press-releases/default.aspx February 2, 2016
http://newsroom.baxalta.com/stories/default.aspx February 2, 2016
http://newsroom.baxalta.com/company-facts/default.aspx February 2, 2016
http://investor.baxalta.com/press-releases/press-release-details/2015/baxalta-gains-health-canada-approval-for-obizur-to-treat-patients-with-acquired-hemophilia-a/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2015/baxalta-gains-eu-marketing-authorization-to-provide-obizur-to-adult-patients-with-acquired-haemophilia-a/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2015/baxaltas-adynovate-meets-endpoints-in-phase-3-study-of-hemophilia-a-patients-under-12-years-of-age/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-and-symphogen-establish-strategic-collaboration-to-accelerate-innovation-in-immuno-oncology/default.aspx March 3, 2016
http://investor.baxalta.com/press-releases/press-release-details/2016/baxalta-and-precision-biosciences-form-global-genome-editing-collaboration-in-immuno-oncology/default.aspx March 3, 2016
http://newsroom.baxalta.com/stories/our-stories/default.aspx February 2, 2016
http://fiercebiotech.com/biotech/cti-biopharma-and-baxalta-complete-submission-of-new-drug-application-for-pacritinib-for October 10, 2016
http://benzinga.com/pressreleases/15/11/n5979605/baxalta-to-advance-care-for-hemophilia-a-patients-with-fda-approval-of- May 5, 2017
http://ewhv.com/news/detail/baxalta-and-symphogen-establish-strategic-collaboratiion-to-accelerate-inno June 6, 2016

Please log in to uncover the email addresses, access the 142 results for baxalta.com, filters and more.

Create a free account

Already have an account? Sign in

More information about baxalta.com

Language of the website: English

Find email addresses from any website

Search contact information of any website in one click.

When you visit a website, click on the icon to find the email addresses related to the website.